• 한국식품과학회지
• /
• 제42권2호
• /
• pp.204-209
• /
• 2010

STZ으로 당뇨를 유발 8주 후 당뇨대조군은 공복혈당이 $451{\pm}42.6\;mg/dL$인데 비해 Kocat-D1-1(Kocat-D1 추출물을 0.25 g/kg/day 투여한 군)에서는 $334.3{\pm}32.9\;mg/dL$, Kocat-D1-2(Kocat-D1 추출물을 1 g/kg/day 투여한 군)에서는 $259.5{\pm}35.0\;mg/dL$로 투여 농도에 의존적으로 당뇨대조군에 비해 유의적 수준으로 혈당이 낮아졌다. OGTT 검사에서도 180분 경과 후에도 당뇨대조군은 포도당 투여전보다 혈당이 $55.5{\pm}5.1\;mg/dL$ 높았으나 Kocat-D1-2는 $17.0{\pm}7.4\;mg/dL$로 유의적으로 낮아졌다. STZ에 의해 유도된 당뇨쥐는 정상대조군에 비해 혈장내의 GOT($411.3{\pm}31.3\;U/L$), GPT($162.3{\pm}23.2\;U/L$) 모두 현저히 증가하였다. 이에 비해 Kocat-D1-2 군에서는 GOT($247.0{\pm}33.4\;U/L$), GPT($116.3{\pm}17.4\;U/L$) 모두 유의적인 수준으로 당뇨대조군에 비해 감소하였다. 알부민 수치 또한 정상대조군 $3.9{\pm}0.1\;U/L$에 비해 당뇨대조군은 $2.7{\pm}0.3\;U/L$으로 낮아졌으나 Kocat-D1-2군에서는 $3.0{\pm}0.1\;U/L$로 증가하였다. HDL-콜레스테롤 수치 또한 정상대조군이 $26.8{\pm}3.9\;mg/dL$인데 비해 당뇨대조군은 $11.7{\pm}1.3\;mg/dL$로 낮아졌다. 그러나 Kocat-D1을 투여한 두 군 모두 각각 $22.3{\pm}2.0$, $26.8{\pm}1.2\;mg/dL$로 유의적인 수준으로 증가하였다. 간조직의 조직학적 관찰에서도 당뇨대조군의 경우 간세포사이에 지방구가 관찰되었으나, Kocat-D1-2는 거의 정상대조군과 유사하였으며 지방구를 관찰 할 수 없었다. 각 실험군의 혈액 중 인슐린 농도를 측정한 결과 정상대조군 $0.18{\pm}0.02\;ng/mL$인데 비해 당뇨대조군은 $0.05{\pm}0.04\;ng/mL$로 낮아졌으나 Kocat-D1-1은 $0.11{\pm}0.05$, Kocat-D1-2는 $0.13{\pm}0.02\;ng/mL$로 증가하였다. 췌장의 베타세포의 상대적 용적을 측정한 결과 Kocat-D1-2 군은 당뇨대조군의 $12.9{\pm}7.9%$에 비해 $49.4{\pm}4.2%$로 유의적인 수준으로 증가하였다. Kocat-D1-1군에서도 당뇨대조군보다 증가하는 경향은 보였으나 유의적인 차이는 없었다. Kocat-D1은 인슐린을 분비를 촉진시켜 혈당을 강하시키는 항당뇨효과를 가지고 있음을 알 수 있었다. 따라서 아직 명확한 학명 규명이 규명되지는 않았지만 Kocat-D1은 의약품 소재 및 기능성 식품 소재로서의 활용가능성이 있음을 본 연구를 통해 확인하였다.

• Radiation Oncology Journal
• /
• 제23권3호
• /
• pp.157-160
• /
• 2005

목적: 저선량 방사선이 당뇨쥐의 해마에서 신경 세포의 증식에 미치는 영향을 확인하기 위해서이다. 대상 및 방법: 정상 쥐를 대상으로 방사선을 조사하지 않은 군, 0.1 Gy 방사선 조사군, 10 Gy 방사선 조사군으로 나눠 방사선이 정상 신경 세포의 증식에 미치는 영향을 확인하였다. 당뇨쥐를 대상으로 한 이차 실험은 방사선을 조사하지 않은 정상 쥐, 방사선을 조사하지 않은 당뇨쥐, 0.01 Gy 방사선 조사한 당뇨쥐, 0.1 Gy를 조사한 당뇨쥐, 1 Gy를 조사한 당뇨쥐, 10 Gy를 조사한 당뇨쥐로 나눠 시행하였다. 5-bromo-2'-deoxyuridine (BrdU)를 이용한 면역 염색을 시행하여 쥐 해마의 치아이랑 세포의 수를 세어 비교하였다. 결과: BrdU 양성 세포의 수는 대상으로 방사선을 조사하지 않은 정상쥐, 0.1 Gy 방사선 조사한 정상쥐, 10 Gy 방사선 조사한 정상쥐에서 각각 $45.95{\pm}3.42/mm^2,\;59.34{\pm}5.20/mm^2,\;19.26{\pm}2.98/mm^2$로 나타났다. 당뇨쥐를 대상으로 한 이차 실험에서 BrdU 양성 세포의 수는 방사선을 조사하지 않은 정상 쥐, 방사선을 조사하지 않은 당뇨쥐, 0.01 Gy 방사선 조사한 당뇨쥐, 0.1 Gy를 조사한 당뇨쥐, 1 Gy를 조사한 당뇨쥐, 10 Gy를 조사한 당뇨쥐에서 각각 $55.44{\pm}8.57/mm^2,\;33.33{\pm}6.46/mm^2,\;67.75{\pm}10.54/mm^2,\;66.63{\pm}10.05/mm^2,\;23.59{\pm}6.37/mm^2,\;14.34{\pm}7.22/mm^2$로 나타났다. 결론: 0.1 Gy 이하의 저선량 방사선은 당뇨쥐의 해마 치아이랑세포의 수를 증가시켜 세포 증식효과를 보이는 것을 확인하였다.

• Biomolecules & Therapeutics
• /
• 제24권5호
• /
• pp.536-542
• /
• 2016

Shuangdan oral liquid (SDO) containing radix Salviae miltiorrhizae (Chinese name Danshen) and cortex moutan (Chinese name Mudanpi) is a traditional Chinese medicine using for treating vascular diseases. Danshensu (DSS) is a main effective monomer composition derived from radix Salviae miltiorrhizae and paeonol (Pae) from cortex moutan. Although the two herbs are widely used in traditional Chinese medicine, the pharmacological functions of their active compositions were not reported. Therefore, the research of DSS and Pae in mechanisms and pharmacodynamics interaction can provide scientific evidence to support clinical application. The diabetic nephropathy (DN) rats which were induced by streptozotocin (STZ) were treated with SDO, DSS, Pae, and DSS+Pae for eight weeks. The positive effects on DN animal models were investigated by detection of physiological and biochemical indexes and oxidative stress markers, within five treatments: SDO, DSS, Pae, DSS+Pae and insulin group. Compared with the model group, the DSS+Pae group improved the renal function, blood lipid metabolism and blood viscosity, increased the vitality of T-SOD or T-AOC and decreased the level of MDA or NO after the treatment. The study was successfully showed that the DSS+Pae group could delay the process of DN, especially in the renal injury part of histopathology changes. Our results suggest that the co-administration of DSS and Pae significantly may play a protective role in DN rats through decreasing the oxidative stress and improving the blood lipid metabolism mechanisms.

• 대한약침학회지
• /
• 제10권3호
• /
• pp.63-69
• /
• 2007

Objectives We performed this study in order to investigate the effects of Sedang-Hwan(世糖丸) and modified Sedang-Hwan(世糖丸變方)on the diabetes mellitus. Methods We injected a vein with 65mg/kg of streptozotocin(STZ) on the rats. And then administered Sedang-Hwan(Sample 1 group); 18.7mg/kg/day, modified Sedang-Hwan; 16.5mg/kg/day(Sample 2 group) to Sample groups and observed the body weight, glucose and insulin levels. Results 1. The Sample 1, 2 groups showed a high suppressive effect of body weight loss compared to Control group. 2. The Sample 1, 2 groups’ glucose level showed a effective in lowering level compared to Control group. 3. The sample 1, 2 groups showed a higher insulin level than Control group. Conclusions Conclusively, modified Sedang-hwan was recognized to have decrease effect of serum glucose of the diabetic rats induced by streptozotocin. It is also required to study on the further detailed mechanism of decrease effect of serum glucose by modified Sedang-hwan.

• 생약학회지
• /
• 제32권4호통권127호
• /
• pp.327-329
• /
• 2001

Cordyceps militaris (CM) has been used as a tonics in the traditional medicine. To investigate the anti-diabetic principle of CM, activity guided fractionation was conducted. Hot water extract of CM was fractionated into 3 parts: above 100,000(A), $100,000{\sim}20,000(B)$, below 20,000(C) in molecular weight using in membrane filter system. All fractions showed mild hypoglycemic activity in streptozotocin (STZ)-induced diabetic rats by oral administration (300 mg/kg). The fraction C which was most active among them was fractionated again into two parts, C-1 and C-2 by Sephadex LH 20 column chromatography. The fraction C-1 showed hypoglycemic activity but C-2 did not show activity compared with control in STZ mice. In glucose-fed hyperglycemic mice, fraction C, C-1 and C-2 also showed significant glucose lowering activity. Their decreasing rates of plasma glucose level after 1 hours administrations of fraction C, C-1 and C-2 were 24.5%, 29.3% and 22.0%, respectively (Tolbutamide: 48.4%). These results suggested that CM has both insulin like and insulin release promoting activity and could be developed as an antidiabetic agent.

• 대한한방내과학회지
• /
• 제27권2호
• /
• pp.444-458
• /
• 2006

In the Present study, the therapeutic hypolipemic effect of water extract of Saengjinyanghyl-tang (SJYHT), a herbal extract mixture for treatment of diabetes in oriental medicine was tested in Streptozotocin-induced diabetic hyperlipemic SD rats. For detect the therapeutic effects, the test articles were once a day dosed for 28 days by gastric gavage at a dosage 1000, 500 and 250mg/kg from 25 days after STZ-dosing, and the changes on body weight and gains, serum LDL, HDL, Triglyceride and Total Cholesterol levels were observed In addition, the effects of test articles were compared to that of Simvastatin, a well known hypolipemic agents 10mg/kg-dosing group. Base on these results, although no meaningful effects were detected on the serum HDL levels, it is concluded that Saengjinyanghyul-tang water extracts have relatively good favorable effect treatment of STZ-induced diabetic hyperlipemia because they showed clear evidences inhibit the increase of serum LDL, Triglyceride and Total Cholesterol levels. Therefore, it is expected that Saengjinyanghyul-tang extract has favorable potency to development hypolipemic drugs. In addition, about 1000mg/kg of Saengjinyanghyul-tang extracts have similar effect compared to that of Simvastatin 10mg/kg. The effective dosage of Saengjinyanghyul-tang water extracts in the present study was considered as below 250mg/kg.

• 한국약용작물학회지
• /
• 제18권1호
• /
• pp.15-21
• /
• 2010

This study was conducted to investigate the effects of Lycii fructus and Astragalus membranaceus mixed extracts on immunomodulators and prevention in a streptozotocin-induced diabetes rat model. A total of 28 male rats were divided into four dietary groups and fed a commercial diet (A), commercial diet plus induced diabetes by a streptozotocin (STZ) injection (B), induced diabetes by STZ plus medicinal crop extracts(I&$H^{(R)}$) diet (C), and medicinal crop extracts (I&$H^{(R)}$) diet (D). Immunoblotting analyses revealed cytokine expression, and ELISA analyses revealed immunoglobulin E and nitric oxide production. As a results, the tumor necrosis factor-$\alpha$ (TNF-$\alpha$) and inducible nitric oxide synthase (iNOS) as a inflammatory cytokine were decreased. Interleukin-6 (IL-6) and signal transducer and activation of transcription 3 (STAT3) cytokine related in diabetes expression through JAK/STAT3 pathway were also decreased. Furthermore, immunoglobulin E and nitric oxide production were decreased in the serum and lens, respectively. These results suggest that Lycii fructus and Astragalus membranaceus mixed extracts provide positive effects on immunomodulators and prevention in diabetes and eye disease complications.

• 동아시아식생활학회지
• /
• 제15권5
• /
• pp.549-557
• /
• 2005

Effects of Acanthopanax senticosus extract (AS) on blood sugar content and serum lipid profiles of streptozotocin-induced diabetic rats were investigated. Experimental groups were classified into four groups, that is, normal control (NC) group, diabetic mellitus (DM) group, AS-fed group and DMAS-fed group. The AS group showed lower feed efficiency than the NC group, but the efficiency of DMAS group was higher than DM group. DMAS group showed the decreased water intake and urine by $45.5\%$ and $23.7\%$ respectively, compared with DM group. Compared with DM group, DMAS group decreased blood sugar by $46.9\%$ and triglyceride by $17.8\%$, total cholesterol by $10.0\%$ and LDL cholesterol by $22.0\%$ in serum, but increased serum HDL cholesterol by $14.4\%$ The relative percentage of liver or kidney per body weight, and the serum ALT activity in DMAS group were lower than those of DM group. There were no significant differences in hepatic glutathione(GSH) contents and total xanthine oxidase(XOD) activities among experimental groups. The hepatic lipid peroxide(LPO) content in DMAS group decreased by $54.6\%$ compared with that in DM group. The XOD (O type) and the ratio of O type to total type of both STZ-treated groups (DM and DMAS) were higher than those of NC group, but less conversion of D to O type was observed in DMAS group than in DM group. There was no significant difference in GST activity between NC and AS, but STZ-treated groups showed lower glutathione S-transferase(GST) activity than NC. In conclusion, it seems that AS reduces blood sugar by inhibiting the activity of xanthine oxidase type O as an oxygen-free radical generating system which induces the tissue damage. Antidiabetic effect of AS may regulate diabetes-induced high lipid profiles in blood.

• 한국잠사곤충학회지
• /
• 제38권2호
• /
• pp.100-107
• /
• 1996

인슐린 의존형 당뇨병 및 인슐린 비의존형 당뇨명 모델동물을 이용하여 오디의 항당뇨 효과를 검정해 보았다. 오디의 투여에 의해 정상 ICR 마우스 및 STZ 투여로 제1형 당뇨병을 유발한 ICR 마우스에서 체중과 혈당치의 유의성 있는 변화를 관찰할 수 없었다. 뿐만 아니라 STZ-유도성 당뇨병 유발억제 효과에 대한 실험에서도 역시 유의성 있는 억제 효과를 나타내지 않았으나 STZ로 유발한 당뇨병에서 용량의존적으로 혈당이 강하되는 경향을 관찰할 수 있었다. 2일령의 랫트에 STZ를 투여하여 제2형 당뇨병을 유발한 실험에서 오디 투여군은 혈당을 유의성 있는 감소를 나타내었으며, 간장의 무게 역시 대조군에 대해 유의성 있게 감소되었다. 그리고 자연발생 제2형 당뇨병 모델동물인 KK 마우스에서 오디 투여군은 대조군에 비해 내당능이 유의성 있게 회복되는 경향을 관찰 할 수 있었다. 오디는 제1형당뇨병에 대해서는 유의한 영향을 미치지 못하는 반면, 제2형당뇨병에 대해서는 유의성 있는 향당뇨 효능을 나타내었다. 이러한 사실은 오디를 이용하여 인슐린 비의존성 당뇨병에 대하여 항당뇨효과를 가진 기능성 식품을 개발 할 수 있는 가능성을 시사하고 있다.

• 대한한의학회지
• /
• 제29권4호
• /
• pp.133-145
• /
• 2008

Objectives: The aim of present study was to investigate recovery effects of Hirudo, which has been used clinically in diabetes therapy. Methods: We established three groups: normal, control, Hirudo, and assigned 6 rats to each group. The normal group was not treated by any process and fed by normal saline. The control & Hirudo groups were administered streptozotocin (STZ) to induce diabetes. Hirudo extract was orally administered to the Hirudo group for 10 days. After 8 weeks, the rats were sacrificed and their body weight, 24hrs urinary protein excretion, glucose, albumin, BUN, creatinine, total-cholesterol, LDL-cholesterol, triglyceride in blood, and level of glycation end-product (AGE) and transforming growth factor (TGF-${\beta}1$) in serum were measured. Morphological profiles and morphometric studies of the kidney cortex, renal transforming growth factor (TGF-${\beta}1$) expression, and renal receptor for advanced glycation end-products (RAGE) expression were studied. Results: The following results were obtained. The protein amount in urine per 24hrs of the Hirudo-treated group as compared to the control group was significantly reduced. The BUN and creatinine level in serum of the Hirudo-treated group as compared to the control group was significantly inhibited. The construction change in kidney of the Hirudo-treated group as compared to the control group was significantly inhibited. The factor of the Hirudo-treated group as compared to the control group was significantly inhibited, which induced the construction change in kidney. Conclusions: The above results suggest that Hirudo partially improved the function of the kidney.